About IP and VITAFOXO
Story is falling, while VitaFOXO is climbing this week. The current IP to VITAFOXO conversion rate is 12.36. Inversely, this means that if you convert 1 VITAFOXO you will get 0.08092 IP. The conversion rate of IP/VITAFOXO has decreased by 0.13% in the last hour (VITAFOXO/IP increased by 0.13%). In the last 24 hours, IP/VITAFOXO shrunk by 5.44%, while VITAFOXO/IP grew by 5.76%.
The exchange rate of Story is decreasing. The current value of 1 IP is 12.36 VITAFOXO. In other words, to buy 5 Story, it would cost you 61.79 VITAFOXO. Inversely, 1 VITAFOXO would allow you to trade for 0.08092 IP while 50 VITAFOXO would convert to 4.05 IP, not including platform or gas fees.
In the last 7 days, the exchange rate has fallen by 25.92%. Meanwhile, in the last 24 hours, the rate has changed by 5.7%, and that the highest exchange rate of 1 IP to VITAFOXO was 13.38 VITAFOXO and the lowest 24 hour value was 1 IP for 12.30 VITAFOXO. Last month, 1 IP was worth 14.99 VITAFOXO. Today, it's down 17.53%. Looking back a year, Story has changed by ∞ VITAFOXO. That means that in a single year, the value of Story has grown by 0%.
Story Market Stats
Story Protocol is a Layer 1 blockchain that allows creators to tokenize their Intellectual Property—ranging from artwork and music to AI-generated content—into programmable assets that can be licensed, remixed, and monetized. IP is the native gas token on the Story Protocol.
VitaFOXO Market Stats
This project will design a new RNA therapeutic that nudges the longevity-linked FOXO3 gene into its health-promoting form to halt the tissue breakdown behind degenerative disc disease—opening a precise, scalable route to drugs that extend healthspan. Dr. Lorna Harries’ lab has identified an innovative way to modulate FOXO3, a well known and yet undrugged longevity target, and propose leveraging it to address chronic lower back pain stemming from degenerative disc disease. They plan to make short, lab-made modified RNA molecules (antisense oligonucleotides) that selectively switch FOXO3’s “good” message on, first in human cells and mini-disc models. Success would yield 1) a lead drug candidate, 2) proof it can restore disc health, and 3) the data needed for patenting and further development. The same molecules could later be adapted to treat many other age-related conditions, helping people stay healthy for longer.
Conversion tables
IP to VITAFOXO values from Today at 7:20 pm
0.5 IP = 6.18 VITAFOXO |
1 IP = 12.36 VITAFOXO |
5 IP = 61.79 VITAFOXO |
10 IP = 123.58 VITAFOXO |
50 IP = 617.91 VITAFOXO |
100 IP = 1,235.83 VITAFOXO |
500 IP = 6,179.13 VITAFOXO |
1,000 IP = 12,358.26 VITAFOXO |
VITAFOXO to IP values from Today at 7:21 pm
0.5 VITAFOXO = 0.04046 IP |
1 VITAFOXO = 0.08092 IP |
5 VITAFOXO = 0.4046 IP |
10 VITAFOXO = 0.8092 IP |
50 VITAFOXO = 4.05 IP |
100 VITAFOXO = 8.09 IP |
500 VITAFOXO = 40.46 IP |
1,000 VITAFOXO = 80.92 IP |
IP to VITAFOXO over time
IP | Today | 24H -6.04% | 1M -21.26% | 1Y 61.54% |
|---|---|---|---|---|
0.5 IP | 6.18 VITAFOXO | 6.55 VITAFOXO | 7.49 VITAFOXO | 2.38 VITAFOXO |
1 IP | 12.36 VITAFOXO | 13.10 VITAFOXO | 14.99 VITAFOXO | 4.75 VITAFOXO |
5 IP | 61.79 VITAFOXO | 65.52 VITAFOXO | 74.93 VITAFOXO | 23.76 VITAFOXO |
10 IP | 123.58 VITAFOXO | 131.05 VITAFOXO | 149.85 VITAFOXO | 47.53 VITAFOXO |
50 IP | 617.91 VITAFOXO | 655.25 VITAFOXO | 749.26 VITAFOXO | 237.64 VITAFOXO |
100 IP | 1,235.83 VITAFOXO | 1,310.50 VITAFOXO | 1,498.52 VITAFOXO | 475.28 VITAFOXO |
500 IP | 6,179.13 VITAFOXO | 6,552.50 VITAFOXO | 7,492.58 VITAFOXO | 2,376.41 VITAFOXO |
1,000 IP | 12,358.26 VITAFOXO | 13,104.99 VITAFOXO | 14,985.16 VITAFOXO | 4,752.82 VITAFOXO |
Frequently asked questions
Related conversions
Learn how to buy popular cryptocurrencies
Discover other cryptocurrencies to currency conversions
Discover other cryptocurrency conversions
Explore other stocks
Start your crypto portfolio today
Sign up for a Coinbase account today and see what the world of decentralized finance can do for you.
This content is being provided to you for informational purposes only, does not constitute an offer, or solicitation of an offer nor a recommendation by Coinbase to buy, sell, or hold any security, financial product, or instrument referenced in the content, and does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Data presented may reflect asset prices traded on the Coinbase exchange as well as other cryptocurrency exchanges and market data platform. Coinbase may charge fees for the processing of cryptocurrency transactions which may not be reflected in the conversion prices displayed. Coinbase is not liable for any errors or delays in content, or for any actions taken in reliance on any content.




